OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Redifferentiation of radioiodine-refractory thyroid cancers
Camille Buffet, Johanna Wassermann, Fábio Hecht, et al.
Endocrine Related Cancer (2020) Vol. 27, Iss. 5, pp. R113-R132
Open Access | Times Cited: 77
Camille Buffet, Johanna Wassermann, Fábio Hecht, et al.
Endocrine Related Cancer (2020) Vol. 27, Iss. 5, pp. R113-R132
Open Access | Times Cited: 77
Showing 1-25 of 77 citing articles:
Genomic alterations in thyroid cancer: biological and clinical insights
Iñigo Landa, Maria E. Cabanillas
Nature Reviews Endocrinology (2023) Vol. 20, Iss. 2, pp. 93-110
Closed Access | Times Cited: 43
Iñigo Landa, Maria E. Cabanillas
Nature Reviews Endocrinology (2023) Vol. 20, Iss. 2, pp. 93-110
Closed Access | Times Cited: 43
Molecular mechanisms of radioactive iodine refractoriness in differentiated thyroid cancer: Impaired sodium iodide symporter (NIS) expression owing to altered signaling pathway activity and intracellular localization of NIS
Ji Min Oh, Byeong‐Cheol Ahn
Theranostics (2021) Vol. 11, Iss. 13, pp. 6251-6277
Open Access | Times Cited: 90
Ji Min Oh, Byeong‐Cheol Ahn
Theranostics (2021) Vol. 11, Iss. 13, pp. 6251-6277
Open Access | Times Cited: 90
A Joint Statement from the American Thyroid Association, the European Association of Nuclear Medicine, the European Thyroid Association, the Society of Nuclear Medicine and Molecular Imaging on Current Diagnostic and Theranostic Approaches in the Management of Thyroid Cancer
Seza Güleç, Sukhjeet Ahuja, Anca M. Avram, et al.
Thyroid (2021) Vol. 31, Iss. 7, pp. 1009-1019
Closed Access | Times Cited: 72
Seza Güleç, Sukhjeet Ahuja, Anca M. Avram, et al.
Thyroid (2021) Vol. 31, Iss. 7, pp. 1009-1019
Closed Access | Times Cited: 72
Enhancing Radioiodine Incorporation into Radioiodine-Refractory Thyroid Cancer with MAPK Inhibition (ERRITI): A Single-Center Prospective Two-Arm Study
Manuel Weber, David Kersting, Burkhard Riemann, et al.
Clinical Cancer Research (2022) Vol. 28, Iss. 19, pp. 4194-4202
Open Access | Times Cited: 47
Manuel Weber, David Kersting, Burkhard Riemann, et al.
Clinical Cancer Research (2022) Vol. 28, Iss. 19, pp. 4194-4202
Open Access | Times Cited: 47
Review article: new treatments for advanced differentiated thyroid cancers and potential mechanisms of drug resistance
Sarah Hamidi, Marie‐Claude Hofmann, Priyanka Iyer, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 23
Sarah Hamidi, Marie‐Claude Hofmann, Priyanka Iyer, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 23
Radioactive Iodine Therapy in Differentiated Thyroid Cancer: An Update on Dose Recommendations and Risk of Secondary Primary Malignancies
Nghi Nguyen, Elena M. Anigati, Neil B. Desai, et al.
Seminars in Nuclear Medicine (2024) Vol. 54, Iss. 4, pp. 488-496
Closed Access | Times Cited: 9
Nghi Nguyen, Elena M. Anigati, Neil B. Desai, et al.
Seminars in Nuclear Medicine (2024) Vol. 54, Iss. 4, pp. 488-496
Closed Access | Times Cited: 9
Larotrectinib-Enhanced Radioactive Iodine Uptake in Advanced Thyroid Cancer
Lionel Groussin, Jérôme Clerc, Olivier Huillard
New England Journal of Medicine (2020) Vol. 383, Iss. 17, pp. 1686-1687
Open Access | Times Cited: 55
Lionel Groussin, Jérôme Clerc, Olivier Huillard
New England Journal of Medicine (2020) Vol. 383, Iss. 17, pp. 1686-1687
Open Access | Times Cited: 55
Dynamic Cancer Cell Heterogeneity: Diagnostic and Therapeutic Implications
Valérie Jacquemin, Mathieu Antoine, Geert Dom, et al.
Cancers (2022) Vol. 14, Iss. 2, pp. 280-280
Open Access | Times Cited: 33
Valérie Jacquemin, Mathieu Antoine, Geert Dom, et al.
Cancers (2022) Vol. 14, Iss. 2, pp. 280-280
Open Access | Times Cited: 33
Molecular Imaging and Theragnostics of Thyroid Cancers
Luca Giovanella, Désirèe Deandreis, Alexis Vrachimis, et al.
Cancers (2022) Vol. 14, Iss. 5, pp. 1272-1272
Open Access | Times Cited: 29
Luca Giovanella, Désirèe Deandreis, Alexis Vrachimis, et al.
Cancers (2022) Vol. 14, Iss. 5, pp. 1272-1272
Open Access | Times Cited: 29
Clinico-pathological factors associated with radioiodine refractory differentiated thyroid carcinoma status
Louise Schubert, A. M. Mbekwe-Yepnang, Johanna Wassermann, et al.
Journal of Endocrinological Investigation (2024) Vol. 47, Iss. 6, pp. 1573-1581
Open Access | Times Cited: 7
Louise Schubert, A. M. Mbekwe-Yepnang, Johanna Wassermann, et al.
Journal of Endocrinological Investigation (2024) Vol. 47, Iss. 6, pp. 1573-1581
Open Access | Times Cited: 7
Redifferentiation-facilitated radioiodine therapy in thyroid cancer
Livia Lamartina, Nadège Anizan, Corinne Dupuy, et al.
Endocrine Related Cancer (2021) Vol. 28, Iss. 10, pp. T179-T191
Open Access | Times Cited: 39
Livia Lamartina, Nadège Anizan, Corinne Dupuy, et al.
Endocrine Related Cancer (2021) Vol. 28, Iss. 10, pp. T179-T191
Open Access | Times Cited: 39
The complex regulation of NIS expression and activity in thyroid and extrathyroidal tissues
Garcilaso Riesco‐Eizaguirre, Pilar Santisteban, Antonio De la Vieja
Endocrine Related Cancer (2021) Vol. 28, Iss. 10, pp. T141-T165
Open Access | Times Cited: 39
Garcilaso Riesco‐Eizaguirre, Pilar Santisteban, Antonio De la Vieja
Endocrine Related Cancer (2021) Vol. 28, Iss. 10, pp. T141-T165
Open Access | Times Cited: 39
Radio-Iodide Treatment: From Molecular Aspects to the Clinical View
Antonio De la Vieja, Garcilaso Riesco‐Eizaguirre
Cancers (2021) Vol. 13, Iss. 5, pp. 995-995
Open Access | Times Cited: 34
Antonio De la Vieja, Garcilaso Riesco‐Eizaguirre
Cancers (2021) Vol. 13, Iss. 5, pp. 995-995
Open Access | Times Cited: 34
Dual targeting of MAPK and PI3K pathways unlocks redifferentiation of Braf-mutated thyroid cancer organoids
Hélène Lasolle, Andréa Alex Schiavo, Adrien Tourneur, et al.
Oncogene (2023) Vol. 43, Iss. 3, pp. 155-170
Open Access | Times Cited: 14
Hélène Lasolle, Andréa Alex Schiavo, Adrien Tourneur, et al.
Oncogene (2023) Vol. 43, Iss. 3, pp. 155-170
Open Access | Times Cited: 14
Redifferentiation of Differentiated Thyroid Cancer: Clinical Insights from a Narrative Review of Literature
Douglas Van Nostrand, Irina Veytsman, Kanchan Kulkarni, et al.
Thyroid (2023) Vol. 33, Iss. 6, pp. 674-681
Closed Access | Times Cited: 13
Douglas Van Nostrand, Irina Veytsman, Kanchan Kulkarni, et al.
Thyroid (2023) Vol. 33, Iss. 6, pp. 674-681
Closed Access | Times Cited: 13
Target Therapy in Thyroid Cancer: Current Challenge in Clinical Use of Tyrosine Kinase Inhibitors and Management of Side Effects
Ivana Puliafito, Francesca Esposito, Angela Prestifilippo, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 21
Ivana Puliafito, Francesca Esposito, Angela Prestifilippo, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 21
CRABP2 Is Associated With Thyroid Cancer Recurrence and Promotes Invasion via the Integrin/FAK/AKT Pathway
Chien‐Liang Liu, Yi‐Chiung Hsu, Chi‐Yu Kuo, et al.
Endocrinology (2022) Vol. 163, Iss. 12
Open Access | Times Cited: 21
Chien‐Liang Liu, Yi‐Chiung Hsu, Chi‐Yu Kuo, et al.
Endocrinology (2022) Vol. 163, Iss. 12
Open Access | Times Cited: 21
Strategies for Radioiodine Treatment: What’s New
Clotilde Sparano, Sophie Moog, Julien Hadoux, et al.
Cancers (2022) Vol. 14, Iss. 15, pp. 3800-3800
Open Access | Times Cited: 20
Clotilde Sparano, Sophie Moog, Julien Hadoux, et al.
Cancers (2022) Vol. 14, Iss. 15, pp. 3800-3800
Open Access | Times Cited: 20
Current and Emerging Radiotracers and Technologies for Detection of Advanced Differentiated Thyroid Cancer: A Narrative Review
Reza Pishdad, Prasanna Santhanam
Cancers (2025) Vol. 17, Iss. 3, pp. 425-425
Open Access
Reza Pishdad, Prasanna Santhanam
Cancers (2025) Vol. 17, Iss. 3, pp. 425-425
Open Access
Circular RNAs in cancer
Yang Guo, Qiang Huang, Heng Yu, et al.
MedComm (2025) Vol. 6, Iss. 2
Open Access
Yang Guo, Qiang Huang, Heng Yu, et al.
MedComm (2025) Vol. 6, Iss. 2
Open Access
Redifferentiation therapy in unresectable or metastatic radioactive iodine refractory thyroid cancer: an International Thyroid Oncology Group statement
Sophie Leboulleux, Laura Boucai, Naifa L. Busaidy, et al.
The Lancet Diabetes & Endocrinology (2025)
Open Access
Sophie Leboulleux, Laura Boucai, Naifa L. Busaidy, et al.
The Lancet Diabetes & Endocrinology (2025)
Open Access
Non-Coding RNAs: Uncharted Mediators of Thyroid Cancer Pathogenesis
Hossein Tabatabaeian, Samantha Peiling Yang, Yvonne Tay
Cancers (2020) Vol. 12, Iss. 11, pp. 3264-3264
Open Access | Times Cited: 29
Hossein Tabatabaeian, Samantha Peiling Yang, Yvonne Tay
Cancers (2020) Vol. 12, Iss. 11, pp. 3264-3264
Open Access | Times Cited: 29
Redox Homeostasis in Thyroid Cancer: Implications in Na+/I− Symporter (NIS) Regulation
Juliana Cazarin, Corinne Dupuy, Denise Pires de Carvalho
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 11, pp. 6129-6129
Open Access | Times Cited: 16
Juliana Cazarin, Corinne Dupuy, Denise Pires de Carvalho
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 11, pp. 6129-6129
Open Access | Times Cited: 16
